학술논문
Peak Concentrations of Ustekinumab After Intravenous Induction Therapy Identify Patients With Crohn’s Disease Likely to Achieve Endoscopic and Biochemical Remission
Document Type
Article
Author
Source
In Clinical Gastroenterology and Hepatology January 2021 19(1):111-118
Subject
Language
ISSN
1542-3565